Dr. Mark Lambrecht is Global Head of Health Care and Life Sciences Advisory at SAS. He and his team operate on the intersection of research, information science and analytical cloud technology to solve advanced analytical and AI challenges at hospitals, pharmaceutical manufacturers and various health care organisations. Prior to joining SAS, he worked in the pharmaceutical industry and obtained a Masters and PhD in Applied Bioscience Engineering, Cell- and Gene Technology at the University of Leuven (Belgium) and conducted Postdoctoral Research at Stanford University (USA).
As in most other sectors, health care is changing at lightning speed. Access to data makes it possible to speed up clinical trials, develop more personalized medication, make quicker and better diagnoses, improve the quality of patient care and save lives. The pandemic has sped up digital transformation in every
Geen sector die de afgelopen twee jaar zo hard onder druk stond als de gezondheidszorg. En ook nu het einde van de pandemie in zicht lijkt, zullen veel uitdagingen rond Healthcare en Life Sciences niet verdwijnen. Gelukkig investeren zowel overheden als ziekenhuizen en farmaceutische bedrijven fors in data en analytics
Nos primeiros dias e semanas de qualquer problema de saúde global generalizado, particularmente num surto de rápida evolução como o coronavírus, existem muitas incógnitas. A visualização de dados pode ser um bom ponto de partida para perceber tendências e transformar dados dispersos em algo útil. A capacidade de visualizar a
